Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1339068

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1339068

Alpha Emitters Market Share, Size, Trends, Industry Analysis Report, By Type of Radionuclide (Radium, Actinium, Lead, Bismuth, and Others); By Application; By Region; Segment Forecast, 2023- 2032

PUBLISHED:
PAGES: 116 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

The global alpha emitters market size is expected to reach USD 1,464.04 million by 2032, according to a new study by Polaris Market Research. The report "Alpha Emitters Market Share, Size, Trends, Industry Analysis Report, By Type of Radionuclide (Radium, Actinium, Lead, Bismuth, and Others); By Application; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rapid increase in awareness regarding the potential benefits of the targeted alpha emitter and the surge in the number of patients with several types of cancers like ovarian cancer, pancreatic cancer, melanoma, and lymphoma, coupled with the rising usage of alpha therapy due to its exceptionally high cell-killing ability, are among the prominent factors influencing the global market growth.

The rapid development of new targeting strategies that deliver alpha emitters specifically to cancer cells, which can be achieved by conjugating alpha-emitting isotopes with specific targeting molecules such as antibodies, peptides, or small molecules, enabling more precise delivery of the radiation dose to cancer cells while sparing healthy tissues, has been further creating lucrative growth opportunities soon. For instance, in June 2022, Alpha Tau Medical developed 'Alpha DaRT" and enrolled 1st patient in its feasibility study to evaluate neo-adjuvant therapy for patients who have prostate cancer.

The growing penetration of automation as an important technological development in alpha emitters, particularly in the production of radiopharmaceuticals, has been pushing the market forward. The use of automated systems for labeling molecules with alpha emitters has made the production of radiopharmaceuticals faster and more efficient, allowing for larger-scale production and lower costs, due to which patients would be able to get access to these therapies more easily or conveniently.

Furthermore, researchers worldwide are exploring the use of combination therapies that combine alpha emitters with other cancer treatments, such as chemotherapy, immunotherapy, or radiation therapy, that could potentially enhance the efficacy of cancer treatments and reduce side effects.

Alpha Emitters Market Report Highlights

Radium segment accounted for largesrt market share in 2022, which is mainly driven by rising penetration as a superior cancer treatment due to beneficial properties like minimizing the narrow toxicity

Ovarian cancer segment is projected to grow at healthy CAGR during the anticipated period, mainly due to increasing new cases worldwide and adoption as an effective alternative to ovarian carcinoma

North America region led the industry market with substantial market share in 2022, owing to presence of several favorable government regulations and highly developed healthcare infrastructure across the region

The global key market players include: IBA Radiopharma Solution, Telix Pharmaceuticals, Novartis, Fusion Pharmaceuticals, Orano Group, Cardinal Health, and Bayer

Polaris Market Research has segmented the alpha emitters market report based on type of radionuclide, application, and region:

Alpha Emitters, Type of Radionuclide Outlook (Revenue - USD Million, 2019 - 2032)

  • Radium
  • Actinium
  • Lead
  • Bismuth
  • Others

Alpha Emitters, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Pancreatic Cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Lymphoma
  • Melanoma
  • Bone Metastasis
  • Others

Alpha Emitters, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Product Code: PM3448

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Alpha Emitters Market Insights

  • 4.1. Alpha Emitters Market - Industry Snapshot
  • 4.2. Alpha Emitters Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased Awareness About the Potential Benefits of Targeted Alpha Therapy
      • 4.2.1.2. Increasing prevalence of modular solutions to optimize the customer productivity
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Short Half-life of Radiopharmaceuticals
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Alpha Emitters Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Alpha Emitters Market, by Type of Radionuclide

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Alpha Emitters, by Type of Radionuclide, 2019-2032 (USD Million)
  • 5.3. Radium
    • 5.3.1. Global Alpha Emitters Market, by Radium, by Region, 2019-2032 (USD Million)
  • 5.4. Actinium
    • 5.4.1. Global Alpha Emitters Market, by Actinium, by Region, 2019-2032 (USD Million)
  • 5.5. Lead
    • 5.5.1. Global Alpha Emitters Market, by Lead, by Region, 2019-2032 (USD Million)
  • 5.6. Bismuth
    • 5.6.1. Global Alpha Emitters Market, by Bismuth, by Region, 2019-2032 (USD Million)
  • 5.7. Others
    • 5.7.1. Global Alpha Emitters Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Alpha Emitters Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • 6.3. Pancreatic Cancer
    • 6.3.1. Global Alpha Emitters Market, by Pancreatic Cancer, by Region, 2019-2032 (USD Million)
  • 6.4. Ovarian Cancer
    • 6.4.1. Global Alpha Emitters Market, by Ovarian Cancer, by Region, 2019-2032 (USD Million)
  • 6.5. Prostate Cancer
    • 6.5.1. Global Alpha Emitters Market, by Prostate Cancer, by Region, 2019-2032 (USD Million)
  • 6.6. Lymphoma
    • 6.6.1. Global Alpha Emitters Market, by Lymphoma, by Region, 2019-2032 (USD Million)
  • 6.7. Melanoma
    • 6.7.1. Global Alpha Emitters Market, by Melanoma, by Region, 2019-2032 (USD Million)
  • 6.8. Bone Metastasis
    • 6.8.1. Global Alpha Emitters Market, by Bone Metastasis, by Region, 2019-2032 (USD Million)
  • 6.9. Others
    • 6.9.1. Global Alpha Emitters Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Alpha Emitters Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Alpha Emitters Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Alpha Emitters Market - North America
    • 7.3.1. North America: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
    • 7.3.2. North America: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.3.3. Alpha Emitters Market - U.S.
      • 7.3.3.1. U.S.: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.3.4. Alpha Emitters Market - Canada
      • 7.3.4.1. Canada: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • 7.4. Alpha Emitters Market - Europe
    • 7.4.1. Europe: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
    • 7.4.2. Europe: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.4.3. Alpha Emitters Market - UK
      • 7.4.3.1. UK: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.4.4. Alpha Emitters Market - France
      • 7.4.4.1. France: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.4.4.2. France: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.4.5. Alpha Emitters Market - Germany
      • 7.4.5.1. Germany: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.4.6. Alpha Emitters Market - Italy
      • 7.4.6.1. Italy: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.4.7. Alpha Emitters Market - Spain
      • 7.4.7.1. Spain: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.4.8. Alpha Emitters Market - Netherlands
      • 7.4.8.1. Netherlands: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.4.9. Alpha Emitters Market - Russia
      • 7.4.9.1. Russia: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • 7.5. Alpha Emitters Market - Asia Pacific
    • 7.5.1. Asia Pacific: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.5.3. Alpha Emitters Market - China
      • 7.5.3.1. China: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.5.3.2. China: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.5.4. Alpha Emitters Market - India
      • 7.5.4.1. India: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.5.4.2. India: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.5.5. Alpha Emitters Market - Malaysia
      • 7.5.5.1. Malaysia: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.5.6. Alpha Emitters Market - Japan
      • 7.5.6.1. Japan: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.5.7. Alpha Emitters Market - Indonesia
      • 7.5.7.1. Indonesia: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.5.8. Alpha Emitters Market - South Korea
      • 7.5.8.1. South Korea: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • 7.6. Alpha Emitters Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.6.3. Alpha Emitters Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.6.4. Alpha Emitters Market - UAE
      • 7.6.4.1. UAE: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.6.5. Alpha Emitters Market - Israel
      • 7.6.5.1. Israel: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.6.6. Alpha Emitters Market - South Africa
      • 7.6.6.1. South Africa: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • 7.7. Alpha Emitters Market - Latin America
    • 7.7.1. Latin America: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.7.3. Alpha Emitters Market - Mexico
      • 7.7.3.1. Mexico: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.7.4. Alpha Emitters Market - Brazil
      • 7.7.4.1. Brazil: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
    • 7.7.5. Alpha Emitters Market - Argentina
      • 7.7.5.1. Argentina: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Bayer
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. IBA Radiopharma
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Actinium Pharmaceutical
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. RadioMedix
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Alpha Tau Medical
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Telix Pharmaceuticals
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Novartis
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Fusion Pharmaceuticals
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Orano Group
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Cardinal Health
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Institute of Radio-elements
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Nordion
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. SHINE Medical
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Medical Solutions
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Isotopia Molecular Imaging
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development
  • 9.16. America Elements
    • 9.16.1. Company Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Recent Development
Product Code: PM3448

List of Tables

  • Table 1 Global Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 2 Global Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 3 Alpha Emitters Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 5 North America: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 6 U.S.: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 7 U.S.: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 8 Canada: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 9 Canada: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 10 Europe: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 11 Europe: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 12 UK: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 13 UK: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 14 France: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 15 France: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 16 Germany: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 17 Germany: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 18 Italy: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 19 Italy: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 20 Spain: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 21 Spain: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 22 Netherlands: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 23 Netherlands: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 24 Russia: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 25 Russia: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 28 China: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 29 China: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 30 India: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 31 India: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 32 Malaysia: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 33 Malaysia: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 34 Japan: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 35 Japan: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 36 Indonesia: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 37 Indonesia: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 38 South Korea: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 39 South Korea: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 44 UAE: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 45 UAE: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 46 Israel: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 47 Israel: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 48 South Africa: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 49 South Africa: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 50 Latin America: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 51 Latin America: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 52 Mexico: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 53 Mexico: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 54 Brazil: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 55 Brazil: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)
  • Table 56 Argentina: Alpha Emitters Market, by Application, 2019-2032 (USD Million)
  • Table 57 Argentina: Alpha Emitters Market, by Type of Radionuclide, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Alpha Emitters Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Application
  • Figure 7 Global Alpha Emitters Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8 Market by Type of Radionuclide
  • Figure 9 Global Alpha Emitters Market, by Type of Radionuclide, 2022 & 2032 (USD Million)
  • Figure 10 Alpha Emitters Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11 Strategic Analysis - Alpha Emitters Market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!